- 15 Jun 2020
- Research & Ideas
A Mass Crisis Can Overwhelm Health Care. Liberia Found a Solution.
Liberia trains community workers to help medical professionals on the front lines of disease control, says Brian Trelstad. Could the model work elsewhere? Open for comment; Comment(s) posted.
- 11 Jun 2020
- Working Paper Summaries
Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design
Without a vaccine for COVID-19, the medical community has turned to a century-old therapy. This paper discusses a market design approach for expanding the collection and distribution of convalescent plasma.
- 09 Jun 2020
- Cold Call Podcast
In a Pandemic, What’s the Best Strategy for the Global Vaccine Alliance?
How should the vaccine alliance Gavi respond to the worldwide need for a cure for the COVID-19 pandemic? Tarun Khanna discusses his case study. Open for comment; Comment(s) posted.
- 02 Jun 2020
- Working Paper Summaries
HBS COVID-19 Global Policy Tracker
The Harvard Business School Covid-19 Global Policy Tracker monitors new developments and changes in government policies throughout this crisis to analyze trends and correlations in countries' responses and economic impact.
- 01 Jun 2020
- Working Paper Summaries
Spreading the Health: Americans' Estimated and Ideal Distributions of Death and Health(care)
Across varying political ideologies and income levels, Americans both underestimate the current extent of inequality of mortality and healthcare, and prefer each to be more equally distributed.
- 01 Jun 2020
- Working Paper Summaries
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
Retail pharmacy data illustrates it can be misleading to use list prices instead of net prices to understand pharmaceutical prices. Analysts and economists working in public policy should be extremely cautious in drawing policy conclusions based on list prices alone.
- 31 May 2020
- Working Paper Summaries
Demystifying the Math of the Coronavirus
This paper provides a conceptual model for the progression of COVID-19 that is somewhat imprecise but that’s very simple and easy to understand. By relying on this description, one can obtain a rough estimate of the impact of various social distancing measures on the rate of growth of new infections.
- 27 May 2020
- Coronavirus
What South Korea Teaches the World About Fighting COVID
South Korea initially had the largest number of Coronavirus infections outside of China, but new cases have decreased sharply. What is the country doing right? asks Doug Chung. Open for comment; Comment(s) posted.
- 20 Apr 2020
- Book
Why COVID-19 Raises the Stakes for Healthy Buildings
Like it or not, humans have become an indoor species, so buildings have a major impact on our health. That's why the Healthy Building Movement is gaining momentum, say John Macomber and Joseph Allen. Open for comment; Comment(s) posted.
- 26 Mar 2020
- Coronavirus
7 Leadership Principles for Managing in the Time of Coronavirus
Leaders managing their organizations through crisis show seven distinctive capabilities, says John A. Quelch. Call them the seven Cs. Open for comment; Comment(s) posted.
- 24 Mar 2020
- Coronavirus
These Coronavirus Heroes Show Us How Crisis Leadership Works
Now is the time for leaders to inspire their organizations to help the world through the COVID-19 crisis. Bill George has a list of authentic leaders who are up to the challenge. Open for comment; Comment(s) posted.
- 27 Feb 2020
- Sharpening Your Skills
How Best Business Practices Can Improve Health Care
Why do Harvard Business School scholars spend so much time and money analyzing health care delivery? Open for comment; Comment(s) posted.
- 02 Jan 2020
- Op-Ed
Medicare for All or Public Option: Can Either Heal Health Care?
A public insurance option could use its scale to hold prices down, but only if the approach avoids the financing gimmicks that are undermining Medicare, say Regina E. Herzlinger and James Wallace. Open for comment; Comment(s) posted.
- 18 Sep 2019
- Working Paper Summaries
Female Inventors and Inventions
Does the gender of inventors make a difference for who benefits from their inventions? Analysis of all U.S. biomedical patents issued between 1976 and 2010 shows that research teams with women were more likely to produce patents addressing women’s health conditions, especially when female researchers led the teams. This link suggests that the dearth of women inventors might also result in fewer female-focused inventions.
- 11 Sep 2019
- Research & Ideas
Germany May Have the Answer for Reducing Drug Prices
In Germany, drugmakers must prove that a new medication’s benefits merit a higher price than existing drugs. Ariel Dora Stern asks whether "value-based pricing" should become the standard elsewhere. Open for comment; Comment(s) posted.
- 28 Aug 2019
- Working Paper Summaries
Who Drives Digital Innovation? Evidence from the US Medical Device Industry
Major industries are undergoing a digital transformation, in which key aspects of new product development are migrating to a software-driven context. In the medical device industry, experience matters, as does the geographic clustering of new product development, which gives advantages to both new entrants and incumbent firms.
- 31 Jul 2019
- Research & Ideas
Distressed Employees? Try Resilience Training
Depressed employees are up to five times more likely to experience work-related problems than employees with chronic physical illnesses. So why aren't employers helping them? asks Ashley Whillans. Open for comment; Comment(s) posted.
- 17 Jun 2019
- Research & Ideas
What Hospitals Must Learn to Compete
3QUESTIONS Why is it so difficult for American health care providers to compete for customers? Raffaella Sadun and Leemore Dafny discuss why health care needs a business strategy. Open for comment; Comment(s) posted.
- 06 May 2019
- Research & Ideas
Consumers Blame Business for Global Health Problems. Can Business Become the Solution?
Millions of people have been harmed by cigarettes, defective merchandise, pollution, addiction and other business by-products. now, pioneering companies are exploring healthier ways to operate, say Amy C. Edmondson and Dr. Howard K. Koh. Open for comment; Comment(s) posted.
Social Interactions in Pandemics: Fear, Altruism, and Reciprocity
An analysis of 89 cities worldwide shows that mobility responds to infection risk, altruism, and reciprocity. Correcting the SIR model to account for this behavior shows that a balanced approach involving stringency measures, in respect of human dignity, and responsible social preferences mitigates the pandemic health and economic costs.